• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西尼地平对无症状非糖尿病高血压患者正常至边缘升高的尿白蛋白/肌酐比值的影响:指数衰减曲线分析。

Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.

机构信息

Department of Cardiology, Kagawa-ken Saiseikai Hospital, Takamatsu, Japan.

出版信息

Clin Drug Investig. 2010;30(10):699-706. doi: 10.2165/11538510-000000000-00000.

DOI:10.2165/11538510-000000000-00000
PMID:20701401
Abstract

BACKGROUND

High-normal urinary albumin excretion has been reported to have clinical significance with respect to progression of proteinuria and hypertension.

OBJECTIVE

We analysed the effect of cilnidipine (10 mg/day) on morning systolic blood pressure (SBP) and urine albumin-creatinine ratio (UACR) in 16 non-diabetic hypertensive patients with a normal to marginally elevated UACR (mean +/- SD 29.4 +/- 21.7; range 7.5-72.9 mg/g creatinine).

METHODS

Sequential home BP and UACR data were fitted to a simple exponential function as follows: where y is SBP (mmHg) or UACR (mg/g creatinine); alpha is the extent of the SBP (mmHg)- or UACR (mg/g creatinine)-lowering effect; beta (days) is the time-constant for SBP or UACR decrease; t is the number of days after the start of cilnidipine administration; and gamma is the finally stabilized SBP (mmHg) or UACR (mg/g creatinine).

RESULTS

Mean +/- SD morning SBP and UACR decreased by 20.4 +/- 11.4 mmHg and 15.2 +/- 13.1 mg/g creatinine, respectively, as determined by coefficient alpha. The mean +/- SD time-constant for UACR decrease was significantly longer than that for BP decrease (43.5 +/- 22.9 vs 15.4 +/- 7.1 days). UACR reduction correlated with pre-treatment UACR values (correlation coefficient [R] = 0.88, p < 0.01) but not with BP decrease.

CONCLUSIONS

The present study demonstrated that cilnidipine reduced UACR in hypertensive patients with normal to marginally elevated UACR independent of its BP-lowering effect.

摘要

背景

高正常范围的尿白蛋白排泄已被报道与蛋白尿和高血压的进展具有临床意义。

目的

我们分析了西尼地平(10mg/天)对 16 例非糖尿病高血压患者清晨收缩压(SBP)和尿白蛋白/肌酐比值(UACR)的影响,这些患者的 UACR 正常至轻度升高(平均值±SD 29.4±21.7;范围 7.5-72.9mg/g 肌酐)。

方法

将连续的家庭血压和 UACR 数据拟合到一个简单的指数函数中,如下所示:其中 y 是 SBP(mmHg)或 UACR(mg/g 肌酐);alpha 是 SBP(mmHg)或 UACR(mg/g 肌酐)降低幅度;beta(天)是 SBP 或 UACR 降低的时间常数;t 是开始西尼地平治疗后的天数;gamma 是最终稳定的 SBP(mmHg)或 UACR(mg/g 肌酐)。

结果

通过系数 alpha 确定,平均±SD 清晨 SBP 和 UACR 分别降低了 20.4±11.4mmHg 和 15.2±13.1mg/g 肌酐。UACR 降低的平均±SD 时间常数明显长于 BP 降低的时间常数(43.5±22.9 vs 15.4±7.1 天)。UACR 降低与治疗前的 UACR 值相关(相关系数 [R] = 0.88,p<0.01),但与 BP 降低无关。

结论

本研究表明,西尼地平降低了 UACR 在 UACR 正常至轻度升高的高血压患者中,独立于其降压作用。

相似文献

1
Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.西尼地平对无症状非糖尿病高血压患者正常至边缘升高的尿白蛋白/肌酐比值的影响:指数衰减曲线分析。
Clin Drug Investig. 2010;30(10):699-706. doi: 10.2165/11538510-000000000-00000.
2
Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.氨氯地平、依福地平与三氯噻嗪对原发性高血压患者家庭血压及偶测尿标本微量白蛋白尿的影响。
Clin Exp Hypertens. 2018;40(5):468-475. doi: 10.1080/10641963.2017.1403617. Epub 2017 Nov 27.
3
L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.L/N型钙通道阻滞剂西尼地平可降低慢性肾脏病患者的血浆醛固酮、蛋白尿和尿肝型脂肪酸结合蛋白水平。
Heart Vessels. 2013 Jul;28(4):480-9. doi: 10.1007/s00380-012-0274-1. Epub 2012 Aug 23.
4
Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study.缬沙坦/氨氯地平联合治疗对中心夜间血压变化与尿白蛋白/肌酐比值的影响:一项 CPET 研究。
Am J Hypertens. 2018 Aug 3;31(9):995-1001. doi: 10.1093/ajh/hpy078.
5
Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.比较 L-型和 L/N 型钙通道阻滞剂在伴有微量白蛋白尿的糖尿病高血压患者中的降蛋白作用:随机(SAKURA)试验中尿微量白蛋白评估肾功能研究。
Int J Med Sci. 2013 Jul 30;10(9):1209-16. doi: 10.7150/ijms.5508. Print 2013.
6
Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.
Hypertens Res. 2001 Jul;24(4):377-83. doi: 10.1291/hypres.24.377.
7
Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.西尼地平对高血压患者的肾脏保护和抗氧化作用。
Hypertens Res. 2012 Nov;35(11):1058-62. doi: 10.1038/hr.2012.96. Epub 2012 Jul 5.
8
The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.L/N 型钙通道阻滞剂(西尼地平)对交感神经兴奋型晨峰高血压的影响:ACHIEVE-ONE 研究结果。
J Clin Hypertens (Greenwich). 2013 Feb;15(2):133-42. doi: 10.1111/jch.12042. Epub 2012 Dec 10.
9
Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipine.使用新型钙拮抗剂西尼地平治疗的原发性高血压患者的动态血压监测
Cardiovasc Drugs Ther. 1997 Mar;11(1):43-8. doi: 10.1023/a:1007795722576.
10
Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis.动脉粥样硬化多族裔研究中非糖尿病参与者的累积收缩压及尿白蛋白与肌酐比值的变化
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1922-9. doi: 10.2215/CJN.02450314. Epub 2014 Sep 8.

本文引用的文献

1
Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats.阿折地平通过改善血管紧张素Ⅱ输注大鼠的肾脏微循环发挥肾脏保护作用。
Nephrol Dial Transplant. 2009 Dec;24(12):3651-8. doi: 10.1093/ndt/gfp407. Epub 2009 Aug 7.
2
Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats.二氢吡啶类钙通道阻滞剂对醛固酮输注大鼠肾损伤的抑制作用
J Hypertens. 2009 Sep;27(9):1855-62. doi: 10.1097/HJH.0b013e32832dda6f.
3
Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
对3-5期慢性肾病高血压患者联合使用钙通道阻滞剂贝尼地平与氨氯地平和血管紧张素受体阻滞剂的抗蛋白尿作用比较。
Hypertens Res. 2009 Apr;32(4):270-5. doi: 10.1038/hr.2009.11. Epub 2009 Feb 27.
4
Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
Eur J Pharmacol. 2009 Mar 1;605(1-3):49-52. doi: 10.1016/j.ejphar.2008.12.041. Epub 2009 Jan 10.
5
Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.T型和L型钙通道阻滞剂对高血压患者的肾脏保护作用:氨氯地平转换为贝尼地平的转换(ABC)研究
Hypertens Res. 2007 Sep;30(9):797-806. doi: 10.1291/hypres.30.797.
6
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.在慢性肾病高血压患者中,钙通道阻滞剂西尼地平联合肾素-血管紧张素抑制治疗的抗蛋白尿作用。
Kidney Int. 2007 Dec;72(12):1543-9. doi: 10.1038/sj.ki.5002623. Epub 2007 Oct 17.
7
High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.高正常水平蛋白尿可预测巴西2型糖尿病患者微量和大量蛋白尿的发生及死亡率增加:一项8年随访研究
Diabet Med. 2007 Oct;24(10):1136-42. doi: 10.1111/j.1464-5491.2007.02209.x. Epub 2007 Jun 11.
8
Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.新型钙通道阻滞剂阿折地平对自发性高血压大鼠全身血流动力学及肾交感神经活性的影响。
Hypertens Res. 2005 Dec;28(12):1017-23. doi: 10.1291/hypres.28.1017.
9
Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.L/N型钙通道拮抗剂西尼地平对Dahl盐敏感大鼠进行性肾损伤的影响。
Biol Pharm Bull. 2006 May;29(5):933-7. doi: 10.1248/bpb.29.933.
10
Heart and kidney: fatal twins?心脏与肾脏:致命组合?
Am J Med. 2006 May;119(5 Suppl 1):S31-9. doi: 10.1016/j.amjmed.2006.01.012.